Your browser doesn't support javascript.
loading
Neuropsychological Test Performance Differentiates Subgroups of Individuals With Adult Moyamoya Disease: A Cross-Sectional Clinical Study.
DeDios-Stern, Samantha L; Gotra, Milena Y; Resch, Zachary J; Jennette, Kyle J; Amin-Hanjani, Sepideh; Charbel, Fady T; Alaraj, Ali; Testai, Fernando D; Thulborn, Keith R; Vargas, Alejandro; Pliskin, Neil H; Soble, Jason R.
Afiliação
  • DeDios-Stern SL; Department of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
  • Gotra MY; Department of Neuro Rehabilitation, Chelsea and Westminster Hospital NHS London Trust, London, UK.
  • Resch ZJ; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
  • Jennette KJ; Department of Neurology, New York University Langone Health, New York, New York, USA.
  • Amin-Hanjani S; Departments of Psychiatry and Neurology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Charbel FT; Department of Neurosurgery, University Hospitals Cleveland Medical Center/Case Western Reserve School of Medicine, Cleveland, Ohio, USA.
  • Alaraj A; Department of Neurosurgery, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Testai FD; Department of Neurosurgery, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Thulborn KR; Department of Neurosurgery, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Vargas A; Department of Neurology and Rehabilitation, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Pliskin NH; Center for Magnetic Resonance Research, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
  • Soble JR; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Neurosurgery ; 2024 Jun 05.
Article em En | MEDLINE | ID: mdl-38836614
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Moyamoya disease (MMD) is a rare noninflammatory disorder involving progressive intracranial vasculopathy and impaired cerebral blood flow in the anterior circulation, resulting in stroke and cognitive impairment. We aimed to characterize cognitive impairment and the possible predictive value of sociodemographic and clinical characteristics of adults with MMD.

METHODS:

This cross-sectional study examined neurocognitive performance in a group of 42 consecutive adult patients (mean age = 40.52 years; 69% female) referred for a presurgical neuropsychological evaluation. Neuropsychological functioning was assessed with a comprehensive battery, and cognitive dysfunction was defined as 1.5 SDs below the mean. Neurocognitive performance correlated with clinical/demographic characteristics and disease markers.

RESULTS:

Most patients (91%) had a history of stroke, and 45% had cognitive deficits, most notably on measures of attention/speed (48%), executive functioning (47%), visuoconstruction (41%), and memory (31%-54%). Only higher educational attainment and poor collateral blood flow in the right hemisphere differentiated cognitively impaired (n = 19) and intact groups (n = 23), and MMD-related characteristics (eg, disease duration, stroke history) did not differentiate the 2 groups.

CONCLUSION:

Consistent with previous work, frontal-subcortical cognitive deficits (eg, deficits in mental speed, attention, executive functioning) were found in nearly half of patients with MMD and better cognitive performance was associated with factors related to cognitive reserve. Angiographic metrics of disease burden (eg, Suzuki rating, collateral flow) and hemodynamic reserve were not consistently associated with poorer cognitive outcomes, suggesting that cognition is a crucial independent factor to assess in MMD and has relevance for treatment planning and functional status.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article